Navignostics
About Navignostics
Navignostics is a company fighting cancer by enabling personalized treatments through spatial single-cell proteomics.
We analyze tumor samples to find the best therapy for each cancerous growth, helping clinicians and researchers develop new drugs. Founded in 2022 as a spin-off from the University of Zurich Bodenmiller Lab, Navignostics combines highly multiplex tumor imaging with advanced data analytics, validated through rigorous clinical research.
Technology and Approach
The company uses multiplex protein imaging and laser ablation-based imaging mass cytometry to detect up to 50 proteins from a single tumor tissue section. Their proprietary computational workflows analyze images for insights into tumor features, facilitating precise treatment decisions and drug development.
A thorough PDF report describes disease mechanisms to support clinicians’ treatment choices and highlight novel signatures for cancer researchers.
Company Values
Navignostics values trust in quality, curiosity, and collaborative growth, aiming to exceed standards and continuously improve cancer care.
Location and Contact
Navignostics AG is located at Tödistrasse 46a, 8810 Horgen, Switzerland. Contact phone: +41 44 224 09 70, Email: [email protected].